A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice
Graft-versus-host disease (GVHD) is a T cell-mediated inflammatory disorder that arises from allogeneic haematopoietic stem cell transplantation and is often fatal. The P2X7 receptor is an extracellular adenosine 5′-triphosphate-gated cation channel expressed on immune cells. Blockade of this recept...
Main Authors: | Amal Elhage, Peter Cuthbertson, Chloe Sligar, Debbie Watson, Ronald Sluyter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/9/2263 |
Similar Items
-
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice
by: Peter Cuthbertson, et al.
Published: (2024-02-01) -
Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice
by: Chloe Sligar, et al.
Published: (2024-01-01) -
Animal Models for the Investigation of P2X7 Receptors
by: Ronald Sluyter, et al.
Published: (2023-05-01) -
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
by: Serena Janho dit Hreich, et al.
Published: (2023-01-01) -
Contrasting roles of the P2X4 receptor in inflammatory bowel disease
by: Ronald Sluyter
Published: (2023-06-01)